Literature DB >> 935888

Hereditary spherocytosis: a study of splenectomized persons.

R F Schilling.   

Abstract

Sixty-one persons splenectomized for hereditary spherocytosis have been studied and compared to 36 nonsplenectomized clinically affected and to 77 nonaffected family members. Serum IgM levels were reduced by 25% and IgD levels were nearly doubled in the splenectomized group. No fatal bacterial infection was identified by history covering a total of 800 postsplenectomy years. Platelet counts remained elevated for many years after removal of the spleen, as did the number of leukocytes, lymphocytes, and monocytes. Heinz bodies were seen in 3% of red cells after splenectomy. Though within the range of "normal," reticulocyte levels and serum bilirubin levels were satistically higher in the splenectomized group than in the nonaffected persons. Hemoglobin levels were higher in splenectomized affected persons than in matched controls of the same sex and maturity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 935888

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  10 in total

1.  Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children.

Authors:  Henry E Rice; Keith T Oldham; Cheryl A Hillery; Michael A Skinner; Sara M O'Hara; Russell E Ware
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

2.  Laparoscopic versus robotic subtotal splenectomy in hereditary spherocytosis. Potential advantages and limits of an expensive approach.

Authors:  Catalin Vasilescu; Oana Stanciulea; Stefan Tudor
Journal:  Surg Endosc       Date:  2012-04-05       Impact factor: 4.584

Review 3.  Hereditary spherocytosis revisited. Eighth annual Paul M. Aggeler Memorial Lecture. Delivered October 25, 1977, San Francisco General Hospital Medical Center.

Authors:  W N Valentine
Journal:  West J Med       Date:  1978-01

4.  Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis.

Authors:  Shelley E Crary; Sarah Troendle; Naveed Ahmad; George R Buchanan
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

5.  Contemporary pediatric splenectomy: continuing controversies.

Authors:  James H Wood; David A Partrick; Taru Hays; Angela Sauaia; Frederick M Karrer; Moritz M Ziegler
Journal:  Pediatr Surg Int       Date:  2011-05-28       Impact factor: 1.827

6.  Clinicopathologic features of young and old sphha/sphha mice. Mutants with congenital hemolytic anemia.

Authors:  L Maggio-Price; R Russell; N S Wolf; C E Alpers; D Engel
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

Review 7.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

8.  Splenic enlargement and hyperfunction as indications for splenectomy in chronic leukemia.

Authors:  S J Mentzer; R T Osteen; H F Starnes; W C Moloney; D Rosenthal; G Canellos; R E Wilson
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

9.  Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury.

Authors:  Ming-Shian Tsai; Sheng-En Chou; Hong-Shiee Lai; Long-Bin Jeng; Cheng-Li Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

10.  Laparoscopic partial splenectomy: indications and results of a multicenter retrospective study.

Authors:  Géraldine Héry; François Becmeur; Laure Méfat; David Kalfa; Patrick Lutz; Laurence Lutz; Jean-Michel Guys; Pascal de Lagausie
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 3.453

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.